VIM and cancer: Vimentin is also implicated in several pathophysiological conditions such as cancer (van Loon et al., 2024), autoimmune and inflammatory diseases, and infection (Kidd et al., 2014; Lazarova and Bordonaro, 2016; Brzozowa et al., 2015; Zhao et al., 2013; Yin et al., 2018; Peng et al., 2022), including wound healing (Eckes et al., 2000) and evading immune surveillance (Peng et al., 2022).